VKH
RCKT icon

Virtu KCG Holdings’s Rocket Pharmaceuticals RCKT Stock Holding History

Virtu KCG Holdings’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$35K Sell
4,598
-3,012
-40% -$22.5K ﹤0.01% 2658
2017
Q1 		$61K Buy
7,610
+4,947
+186% +$33.3K ﹤0.01% 2798
2016
Q4 		$65K Buy
+2,663
New +$76K ﹤0.01% 3031

Other funds holding RCKT

RCP
Rho Capital Partners New York $20.4M AUM
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Virtu KCG Holdings's RCKT Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Rocket Pharmaceuticals (RCKT) stake by 40% in Q2 2017, selling an estimated $22.5K and leaving 4,598 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #2658.

Virtu KCG Holdings first reported a position in RCKT in Q4 2016 and has held it in 3 quarters since. The position peaked at $65K in Q4 2016. 51 funds tracked by Wall St. Rank hold RCKT as of Q2 2017.

  • Virtu KCG Holdings held 4,598 shares of Rocket Pharmaceuticals worth $35K as of Q2 2017.
  • Virtu KCG Holdings sold 3,012 Rocket Pharmaceuticals shares in Q2 2017, an estimated $22.5K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2658 holding.
  • Virtu KCG Holdings first reported a position in Rocket Pharmaceuticals in Q4 2016 and has held it in 3 quarters since.
  • Virtu KCG Holdings's Rocket Pharmaceuticals position peaked at $65K in Q4 2016.
  • 51 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.